| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/31/2007 | WO2007062335A2 New pleuromutilin derivative and its use |
| 05/31/2007 | WO2007062334A2 New pleuromutilin derivative and its use |
| 05/31/2007 | WO2007062333A2 New pleuromutilin derivative and its use |
| 05/31/2007 | WO2007062325A1 Methods for reducing the amount of proinflammatory substance in animal tissue or body fluid |
| 05/31/2007 | WO2007062318A2 Chemical compounds |
| 05/31/2007 | WO2007062288A2 Chemical synthesis of a highly potent epothilone |
| 05/31/2007 | WO2007062272A1 Materials and methods for treating viral infections with a cysteamine compound |
| 05/31/2007 | WO2007062266A2 Ganaxolone formulations and methods for the making and use thereof |
| 05/31/2007 | WO2007062230A2 Nuclear receptor binding agents |
| 05/31/2007 | WO2007062228A1 Sustained-release formulation of zonisamide |
| 05/31/2007 | WO2007062222A2 Inhibition of cell proliferation |
| 05/31/2007 | WO2007062193A1 Heterocycle-substituted 3-alkyl azetidine derivatives |
| 05/31/2007 | WO2007062190A2 Chemical compounds |
| 05/31/2007 | WO2007062186A2 Methods of using small molecule compounds for neuroprotection |
| 05/31/2007 | WO2007062175A2 Spiro-substituted tricyclic heterocycles cxcr3 antagonists |
| 05/31/2007 | WO2007062151A2 Chemical compounds |
| 05/31/2007 | WO2007062148A2 Chemical compounds |
| 05/31/2007 | WO2007062147A1 Crystal forms of cinacalcet hci and processes for their preparation |
| 05/31/2007 | WO2007062145A2 Chemical compounds |
| 05/31/2007 | WO2007062119A1 Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity |
| 05/31/2007 | WO2007062107A2 Immunostimulatory oligoribonucleotides |
| 05/31/2007 | WO2007062101A2 Intraocular pressure-regulated early genes and uses thereof |
| 05/31/2007 | WO2007062093A2 Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor |
| 05/31/2007 | WO2007062076A2 Dexrazoxane formulations and methods |
| 05/31/2007 | WO2007062067A2 Chemical compounds |
| 05/31/2007 | WO2007062043A1 Method of activating murine toll-like receptor 8 |
| 05/31/2007 | WO2007062030A2 Quinuclidinone derivatives as anticancer agents |
| 05/31/2007 | WO2007062028A2 Treatment of qt interval prolongation and diseases associated therewith |
| 05/31/2007 | WO2007062023A2 Items containing a human pheromone component |
| 05/31/2007 | WO2007062015A2 Methods of treating ischemic related conditions |
| 05/31/2007 | WO2007062007A1 Beta-secretase modulators and methods of use |
| 05/31/2007 | WO2007061995A2 Biomarkers for statin-induced myopathy or rhabdomyolysis |
| 05/31/2007 | WO2007061978A1 Spirocyclic compounds as hdac inhibitors |
| 05/31/2007 | WO2007061942A2 Compositions for disrupting and inhibiting reconstitution of wound biofilm |
| 05/31/2007 | WO2007061930A1 Beta-secretase modulators and methods of use |
| 05/31/2007 | WO2007061909A1 Thiazoles for the treatment of proliferative disorders |
| 05/31/2007 | WO2007061880A1 Spirocyclic compounds as hdac inhibitors |
| 05/31/2007 | WO2007061878A2 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations |
| 05/31/2007 | WO2007061874A2 Methods and compositions for use in treating cancer |
| 05/31/2007 | WO2007061871A1 High-potency sweetener composition with phytosterol and compositions sweetened therewith |
| 05/31/2007 | WO2007061868A2 Treatment of stereotypic, self-injurious and compulsive behaviors using specific serotonin reuptake inhibitors and antagonists of nmda receptors |
| 05/31/2007 | WO2007061862A2 2-keto-oxazoles as modulators of fatty acid amide hydrolase |
| 05/31/2007 | WO2007061849A2 Method of generating amorphous solid for water-insoluble pharmaceuticals |
| 05/31/2007 | WO2007061829A2 Pharmaceutical composition |
| 05/31/2007 | WO2007061828A2 Pharmaceutical compositions comprising buprenorphine |
| 05/31/2007 | WO2007061820A2 Dissolution of arterial cholesterol plaques by a class of pharmacological compounds |
| 05/31/2007 | WO2007061803A1 High-potency sweetener composition with c-reactive protein reducing substance and compositions sweetened therewith |
| 05/31/2007 | WO2007061798A2 Nicotinoyl riboside compositions and methods of use |
| 05/31/2007 | WO2007061795A1 Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses |
| 05/31/2007 | WO2007061783A1 Treatment and prevention of bone loss using resolvins |
| 05/31/2007 | WO2007061764A2 Tricyclic compounds useful as inhibitors of kinases |
| 05/31/2007 | WO2007061763A2 Indole orexin receptor antagonists |
| 05/31/2007 | WO2007061752A2 Biocompatible latent emulsifiers |
| 05/31/2007 | WO2007061739A2 Pharmaceutical compositions comprising buprenorphine |
| 05/31/2007 | WO2007061714A1 Hiv integrase inhibitors |
| 05/31/2007 | WO2007061696A2 Spirolactam bicyclic cgrp receptor antagonists |
| 05/31/2007 | WO2007061695A2 Bicyclic spirohydantoin cgrp receptor antagonists |
| 05/31/2007 | WO2007061694A2 Spirohydantoin tricyclic cgrp receptor antagonists |
| 05/31/2007 | WO2007061692A2 Spirolactam tricyclic cgrp receptor antagonists |
| 05/31/2007 | WO2007061677A2 Spirolactam aryl cgrp receptor antagonists |
| 05/31/2007 | WO2007061676A2 Spirohydantoin aryl cgrp receptor antagonists |
| 05/31/2007 | WO2007061670A1 Beta-secretase modulators and methods of use |
| 05/31/2007 | WO2007061661A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 05/31/2007 | WO2007061555A1 Process for synthesizing remifentanil |
| 05/31/2007 | WO2007061554A2 Dosage of 4-aminopyridine derivatives for treatment of central nervous system injuries |
| 05/31/2007 | WO2007061458A2 S1p receptor modulating compounds and use thereof |
| 05/31/2007 | WO2007061415A1 Pharmaceutical compositions of telmisartan |
| 05/31/2007 | WO2007061360A2 Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides |
| 05/31/2007 | WO2007061337A1 Water-soluble antiviral agent based on silver-cistine compound and method of preparing thereof |
| 05/31/2007 | WO2007061274A1 Universal kit for cell lysis |
| 05/31/2007 | WO2007061256A1 Novel use of ubiquitin c-terminal hydrolase-l1 |
| 05/31/2007 | WO2007061237A1 Composition for anti-inflammation |
| 05/31/2007 | WO2007061236A1 Cleaner for precaution against of cow's hoof, manufacturing method thereof, and using method thereof |
| 05/31/2007 | WO2007061200A1 Composition having effect on treatment and prevention of dry eye syndrome |
| 05/31/2007 | WO2007061182A1 A method for preventing and treating the disease caused by vascular damage and the use thereof |
| 05/31/2007 | WO2007061130A1 Anti-tumor agent for multiple myeloma |
| 05/31/2007 | WO2007061127A1 Anti-tumor agent for multiple myeloma |
| 05/31/2007 | WO2007061114A1 Pharmaceutical composition for prevention or treatment of neurogenic pain |
| 05/31/2007 | WO2007061102A1 Fermentation and culture method, fermented plant extract, composition containing fermented plant extract, method for producing lipopolysaccharide and lipopolysaccharide |
| 05/31/2007 | WO2007061094A1 Pharmaceutical comprising ppar agonist |
| 05/31/2007 | WO2007061074A1 Novel bisboron compound |
| 05/31/2007 | WO2007061028A1 Gel composition for sterilization |
| 05/31/2007 | WO2007060992A1 Agent for preventing or improving metabolic syndrome or insulin-resistance syndrome |
| 05/31/2007 | WO2007060976A1 Novel ascochlorin derivative compounds and medicinal compositions containing the same |
| 05/31/2007 | WO2007060974A1 Pharmaceutical for use in the treatment of ureterolithiasis |
| 05/31/2007 | WO2007060924A1 PROTECTING AGENT FOR PANCREATIC β-CELL |
| 05/31/2007 | WO2007060918A1 Novel memory ctl induction potentiator |
| 05/31/2007 | WO2007060911A1 Aloe vera extract, process for production of aloe vera extract, and ameliorating agent for hyperglycemia |
| 05/31/2007 | WO2007060899A1 Application of actin-binding protein to disease associated with cell motility |
| 05/31/2007 | WO2007060886A1 Therapeutic agent for neurodegenerative disease |
| 05/31/2007 | WO2007060821A1 Bicyclic cinnamide compound |
| 05/31/2007 | WO2007060811A1 Process for production of fucoxanthinol |
| 05/31/2007 | WO2007060810A1 Morpholine type cinnamide compound |
| 05/31/2007 | WO2007060802A1 Solid pharmaceutical preparation and pharmaceutical preparation composition |
| 05/31/2007 | WO2007060715A1 Method of screening interleukin-6 (il-6) signal transduction inhibitor |
| 05/31/2007 | WO2007060686A1 Novel loganin analogues and a process for the preparation thereof |
| 05/31/2007 | WO2007060684A1 An improved process for the isolation of arjunic acid from the bark of the tree terminalia arjuna and the use of this compound in the treatment of cancer |
| 05/31/2007 | WO2007060682A1 Effervescent granular formulations of antiretroviral drugs |
| 05/31/2007 | WO2007060662A2 Process for preparing pyridinamines and novel polymorphs thereof |
| 05/31/2007 | WO2007060652A1 Beta glycolipids as immuno-modulators |